A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and Chp (R-Chp) Versus Rituximab and Chop (R-Chop) In Previously Untreated Patients with Diffuse Large B-Cell Lymphoma

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/HAWKE/51
NMA SSA Reference Number: SSA/18/MonH/530
Monash Health Ref Number: RES-18-0000-453X
Effective start/end date29/03/1928/03/24


  • clinical trial
  • phase 3 study
  • treatment efficacy
  • b-cell lymphoma